These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 19652095)

  • 1. Response gene to complement 32, a novel hypoxia-regulated angiogenic inhibitor.
    An X; Jin Y; Guo H; Foo SY; Cully BL; Wu J; Zeng H; Rosenzweig A; Li J
    Circulation; 2009 Aug; 120(7):617-27. PubMed ID: 19652095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kallistatin is a new inhibitor of angiogenesis and tumor growth.
    Miao RQ; Agata J; Chao L; Chao J
    Blood; 2002 Nov; 100(9):3245-52. PubMed ID: 12384424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vasohibin family: a negative regulatory system of angiogenesis genetically programmed in endothelial cells.
    Sato Y; Sonoda H
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):37-41. PubMed ID: 17095714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down syndrome candidate region 1-like 1 (DSCR1-L1) mimics the inhibitory effects of DSCR1 on calcineurin signaling in endothelial cells and inhibits angiogenesis.
    Gollogly LK; Ryeom SW; Yoon SS
    J Surg Res; 2007 Sep; 142(1):129-36. PubMed ID: 17610901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response gene to complement 32 promotes vascular lesion formation through stimulation of smooth muscle cell proliferation and migration.
    Wang JN; Shi N; Xie WB; Guo X; Chen SY
    Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):e19-26. PubMed ID: 21636805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
    Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
    Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternatively spliced tissue factor promotes plaque angiogenesis through the activation of hypoxia-inducible factor-1α and vascular endothelial growth factor signaling.
    Giannarelli C; Alique M; Rodriguez DT; Yang DK; Jeong D; Calcagno C; Hutter R; Millon A; Kovacic JC; Weber T; Faries PL; Soff GA; Fayad ZA; Hajjar RJ; Fuster V; Badimon JJ
    Circulation; 2014 Oct; 130(15):1274-86. PubMed ID: 25116956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
    Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
    Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semaphorin-3F is an inhibitor of tumor angiogenesis.
    Kessler O; Shraga-Heled N; Lange T; Gutmann-Raviv N; Sabo E; Baruch L; Machluf M; Neufeld G
    Cancer Res; 2004 Feb; 64(3):1008-15. PubMed ID: 14871832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An N-terminal 80 kDa recombinant fragment of human thrombospondin-2 inhibits vascular endothelial growth factor induced endothelial cell migration in vitro and tumor growth and angiogenesis in vivo.
    Noh YH; Matsuda K; Hong YK; Kunstfeld R; Riccardi L; Koch M; Oura H; Dadras SS; Streit M; Detmar M
    J Invest Dermatol; 2003 Dec; 121(6):1536-43. PubMed ID: 14675207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
    Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
    Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a).
    Kim JS; Chang JH; Yu HK; Ahn JH; Yum JS; Lee SK; Jung KH; Park DH; Yoon Y; Byun SM; Chung SI
    J Biol Chem; 2003 Aug; 278(31):29000-8. PubMed ID: 12746434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of p27(Kip1) by doxycycline-regulated adenoviral vectors inhibits endothelial cell proliferation and migration and impairs angiogenesis.
    Goukassian D; Díez-Juan A; Asahara T; Schratzberger P; Silver M; Murayama T; Isner JM; Andrés V
    FASEB J; 2001 Sep; 15(11):1877-85. PubMed ID: 11532967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuropeptide catestatin acts as a novel angiogenic cytokine via a basic fibroblast growth factor-dependent mechanism.
    Theurl M; Schgoer W; Albrecht K; Jeschke J; Egger M; Beer AG; Vasiljevic D; Rong S; Wolf AM; Bahlmann FH; Patsch JR; Wolf D; Schratzberger P; Mahata SK; Kirchmair R
    Circ Res; 2010 Nov; 107(11):1326-35. PubMed ID: 20930149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway.
    Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ
    Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the oxygen-regulated protein ORP150 accelerates wound healing by modulating intracellular VEGF transport.
    Ozawa K; Kondo T; Hori O; Kitao Y; Stern DM; Eisenmenger W; Ogawa S; Ohshima T
    J Clin Invest; 2001 Jul; 108(1):41-50. PubMed ID: 11435456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrb2 promotes endothelial progenitor cell-mediated postischemic neovascularization.
    Wang X; Huang G; Mu J; Cong Z; Chen S; Fu D; Qi J; Li Z
    Theranostics; 2020; 10(21):9899-9912. PubMed ID: 32863967
    [No Abstract]   [Full Text] [Related]  

  • 20. sMEK1 inhibits endothelial cell proliferation by attenuating VEGFR-2-dependent-Akt/eNOS/HIF-1α signaling pathways.
    Kim BR; Seo SH; Park MS; Lee SH; Kwon Y; Rho SB
    Oncotarget; 2015 Oct; 6(31):31830-43. PubMed ID: 26378810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.